<DOC>
	<DOCNO>NCT01974622</DOCNO>
	<brief_summary>The purpose research use approve drug ( Visudyne ) neovascular age-related macular degeneration , essentially choroidal neovascularization permeability vascular proliferation retinal circulation , treat another permeable abnormality - retinal capillary abnormality - locate eccentric central portion macula foveal region .</brief_summary>
	<brief_title>ICG-Guided Photodynamic Therapy Treatment Retinal Capillary Abnormalities : A Pilot Study</brief_title>
	<detailed_description>The study include 30 patient diagnosed retinal capillary abnormality include 2 follow-up visit 6 12 month post-procedure determine treatment effective treating disorder . It anticipate approximately half patient require additional treatment . Patients enrol patient population 50 year age old , male female . Pregnant woman woman normal child bearing age exclude since adequate well-controlled study use photodynamic therapy pregnant woman . Any retinal vascular abnormality standard care method treatment also exclude study population .</detailed_description>
	<mesh_term>Vascular Diseases</mesh_term>
	<mesh_term>Verteporfin</mesh_term>
	<criteria>â€¢ Individuals 50 year age old . Patients retinal capilary abnormalities/vascular disease macular telangiectasia type I type II , retinal arteriolar macroanurysms , retinal angiomous proliferation ( RAP ) . Patients diabetic retinopathy branch retinal vein occlusion Other patient nonresponders approve treatment method Patients whose disease approve method treatment . Pregnant woman woman normal child bearing age .</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2013</verification_date>
</DOC>